Join Now

Utah Life Sciences Companies' COVID-19 News

September 25, 2020
IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration

IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung Test™ for lung cancer has been formally accepted for submission to China’s National Medical Products Administration (NMPA), formerly known as the Chinese Food and Drug Administration (CFDA).  Mr. Jared Bauer, IONIQ Sciences CEO, stated, “We are excited […]

September 25, 2020
SDP Oncology Announces New Data from Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase 1 study evaluating dubermatinib (TP-0903) in patients with advanced solid tumors.  “These preliminary data presented at ESMO 2020 are encouraging as we learn more about how dubermatinib may inhibit the AXL kinase protein and sensitize cancer cells […]

September 25, 2020
RenalytixAI Receives California Commercial Lab Certification

RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. This means that KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with […]

September 18, 2020
The Point Kick Off

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

September 18, 2020
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

September 11, 2020
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

July 17, 2020
BioFire Respiratory Panel with COVID Target Scores CE Mark

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking.  “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

July 17, 2020
PhotoPharmics Stay-At-Home Trial for People with Parkinson’s

This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]

May 5, 2020
AdvaMed Request for Tariff Exclusions for Medical Technology Products

The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]

March 20, 2020
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

March 17, 2020
BioUtah COVID-19 Life Sciences Survey

TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including: Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state Indentifing funding sources from […]

March 3, 2020
Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco

March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that recently reported it had received a CE marking for its COVID-19 coronavirus assay, announced today that it has been requested to speak at […]